81643-9270 : Floxuridine 500 mg Intra-arterial Injection, Powder, Lyophilized, for Solution


NDC81643-9270
Labeler: Cerona Therapeutics, Inc.
Product Type: Human Prescription Drug
Drug Name:  Floxuridine
Dosage Form: Intra-arterial Injection, Powder, Lyophilized, for Solution
Application #: ANDA075387
Rev. Date: 


NDC Package Codes:

  • 81643-9270-1: 1 VIAL IN 1 BOX, UNIT‑DOSE (81643‑9270‑1) > 5 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION IN 1 VIAL

Active Ingredients:

  • Floxuridine

Dosage Strength:

  • 500 mg

Pharmaceutical Classes:

  • Antimetabolite [EPC]
  • Deoxyuridine [CS]

Related Products:

Based on records with the same trade name.
  • 0143-9270 Floxuridine 100 mg/ml Intra-arterial Injection, Powder, Lyophilized, for Solution by West-ward Pharmaceuticals Corp
  • 55390-135 Floxuridine 500 mg/5ml Intra-arterial Injection, Powder, Lyophilized, for Solution by Bedford Laboratories
  • 63323-145 Floxuridine 500 mg/5ml Intra-arterial Injection, Powder, Lyophilized, for Solution by App Pharmaceuticals, LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 81643-9270 QR Code

< Prev: 81641-001Next: 81646-143 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.